These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 20600869

  • 1. Radical changes in multiple sclerosis pathogenesis.
    van Horssen J, Witte ME, Schreibelt G, de Vries HE.
    Biochim Biophys Acta; 2011 Feb; 1812(2):141-50. PubMed ID: 20600869
    [Abstract] [Full Text] [Related]

  • 2. Antioxidant therapy in multiple sclerosis.
    Mirshafiey A, Mohsenzadegan M.
    Immunopharmacol Immunotoxicol; 2009 Feb; 31(1):13-29. PubMed ID: 18763202
    [Abstract] [Full Text] [Related]

  • 3. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
    Lim JL, Wilhelmus MM, de Vries HE, Drukarch B, Hoozemans JJ, van Horssen J.
    Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
    [Abstract] [Full Text] [Related]

  • 4. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J, Drexhage JA, Flor T, Gerritsen W, van der Valk P, de Vries HE.
    Free Radic Biol Med; 2010 Nov 01; 49(8):1283-9. PubMed ID: 20673799
    [Abstract] [Full Text] [Related]

  • 5. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?
    de Vries HE, Witte M, Hondius D, Rozemuller AJ, Drukarch B, Hoozemans J, van Horssen J.
    Free Radic Biol Med; 2008 Nov 15; 45(10):1375-83. PubMed ID: 18824091
    [Abstract] [Full Text] [Related]

  • 6. [Oxidative stress in multiple sclerosis].
    Miller E, Mrowicka M, Zołyński K, Kedziora J.
    Pol Merkur Lekarski; 2009 Dec 15; 27(162):499-502. PubMed ID: 20120717
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology.
    Schreibelt G, van Horssen J, van Rossum S, Dijkstra CD, Drukarch B, de Vries HE.
    Brain Res Rev; 2007 Dec 15; 56(2):322-30. PubMed ID: 17761296
    [Abstract] [Full Text] [Related]

  • 8. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
    Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Brück W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R.
    Brain; 2011 Mar 15; 134(Pt 3):678-92. PubMed ID: 21354971
    [Abstract] [Full Text] [Related]

  • 9. Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis.
    Fetisova E, Chernyak B, Korshunova G, Muntyan M, Skulachev V.
    Curr Med Chem; 2017 Mar 15; 24(19):2086-2114. PubMed ID: 28302008
    [Abstract] [Full Text] [Related]

  • 10. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.
    Gilgun-Sherki Y, Melamed E, Offen D.
    J Neurol; 2004 Mar 15; 251(3):261-8. PubMed ID: 15015004
    [Abstract] [Full Text] [Related]

  • 11. [Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase-1 in the pathogenesis of multiple sclerosis].
    Berbecki J, Mitosek-Szewczyk K, Kurzepa J, Nastaj M, Łobejko K, Stelmasiak Z.
    Wiad Lek; 2011 Mar 15; 64(1):31-6. PubMed ID: 21812361
    [Abstract] [Full Text] [Related]

  • 12. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.
    J Neurol Sci; 2005 Jun 15; 233(1-2):145-62. PubMed ID: 15896810
    [Abstract] [Full Text] [Related]

  • 13. Mitochondria in multiple sclerosis.
    Ghafourifar P, Mousavizadeh K, Parihar MS, Nazarewicz RR, Parihar A, Zenebe WJ.
    Front Biosci; 2008 Jan 01; 13():3116-26. PubMed ID: 17981781
    [Abstract] [Full Text] [Related]

  • 14. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
    Carvalho AN, Firuzi O, Gama MJ, Horssen JV, Saso L.
    Curr Drug Targets; 2017 Mar 30; 18(6):705-718. PubMed ID: 27033198
    [Abstract] [Full Text] [Related]

  • 15. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M.
    Chem Biol Interact; 2006 Mar 10; 160(1):1-40. PubMed ID: 16430879
    [Abstract] [Full Text] [Related]

  • 16. The role of microglial activation in disease progression.
    Correale J.
    Mult Scler; 2014 Sep 10; 20(10):1288-95. PubMed ID: 24812046
    [Abstract] [Full Text] [Related]

  • 17. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression.
    van Horssen J, Schreibelt G, Drexhage J, Hazes T, Dijkstra CD, van der Valk P, de Vries HE.
    Free Radic Biol Med; 2008 Dec 15; 45(12):1729-37. PubMed ID: 18930811
    [Abstract] [Full Text] [Related]

  • 18. Macrophages and neurodegeneration.
    Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD.
    Brain Res Brain Res Rev; 2005 Apr 15; 48(2):185-95. PubMed ID: 15850657
    [Abstract] [Full Text] [Related]

  • 19. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Zhang Z, Schittenhelm J, Meyermann R, Schluesener HJ.
    Neuropathol Appl Neurobiol; 2008 Apr 15; 34(2):231-40. PubMed ID: 17983427
    [Abstract] [Full Text] [Related]

  • 20. Metal ions and oxidative protein modification in neurological disease.
    Sayre LM, Moreira PI, Smith MA, Perry G.
    Ann Ist Super Sanita; 2005 Apr 15; 41(2):143-64. PubMed ID: 16244388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.